IPP Bureau
Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey
By IPP Bureau - June 11, 2026
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Evonik unveils probiotic advance in fight against antibiotic resistance
By IPP Bureau - June 11, 2026
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
By IPP Bureau - June 11, 2026
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
Glenmark launches Winlevi across key European markets
By IPP Bureau - June 11, 2026
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
ASMS explores strategic research collaboration with Mediciti Institute
By IPP Bureau - June 11, 2026
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Cloudnine Hospitals launches one-year fellowship for obstetricians and gynaecologists
By IPP Bureau - June 11, 2026
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies
By IPP Bureau - June 11, 2026
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound
By IPP Bureau - June 11, 2026
The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access
By IPP Bureau - June 11, 2026
The Prayagraj lab is designed to handle both routine and specialised testing
DFE Pharma wins third straight EcoVadis Gold Medal
By IPP Bureau - June 11, 2026
The award places the company in the top 5% globally
Dr. Alka Rao becomes first woman director of CSIR-IMTECH
By IPP Bureau - June 11, 2026
Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
GSK bets big on oncology with $10.6 billion Nuvalent acquisition
By IPP Bureau - June 10, 2026
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Ten years on, PMSMA continues to shape safer motherhood in India
By IPP Bureau - June 10, 2026
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
By IPP Bureau - June 10, 2026
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
By IPP Bureau - June 10, 2026
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
